Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Strong Initial Assay Results for its Fall 2024 Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Technology Scientific & Technical Instruments
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > RE:RE:New Press Release - VENTRIPOINT and ASCEND Cardiovasc
View:
Post by chry200030 on Dec 18, 2024 10:15am

RE:RE:New Press Release - VENTRIPOINT and ASCEND Cardiovasc

All Aboard.. !!
Comment by jopatclo on Dec 18, 2024 1:29pm
Interesting 8. This is a non-exclusive license so we can go forward with other partners to drive adoption of the VMS+.(maybe  now Mayo Clinic has spurred some massive attention and calls ? GEHC,Philips,Siemens,and more lphants) see?  @cardinalMAyo clinic has spurred some massive attention and calls about 3 hours ago 0 and good comment  ...more  
Comment by G1945V on Dec 18, 2024 3:04pm
Hold on  ......  Wait for Graham to get on board! G1945V
Comment by jopatclo on Dec 18, 2024 3:48pm
This post has been removed in accordance with Community Policy
Comment by jopatclo on Dec 18, 2024 10:31pm
now 0.10 on TSX-V GranhamB's Fud Sheep or Puppets with your fake accounts go to denigrate as usual good news...you be the judge between GranhamB. and Dr. Jeff Soble, CEO of ASCEND Cardiovascular. "ASCEND is on a mission to provide a powerful, fully integrated, best-of-breed echocardiography workflow solution to its customers,” stated Dr. Jeff Soble, CEO of ASCEND Cardiovascular ...more  
VentriPoint Diagnostics Ltd